Introduction {#s1}
============

Chloride is the most abundant, soluble anion in the body. Cytosolic chloride can be as low as \~45 mM, while extracellular chloride is \~110 mM ([@bib75]), ([@bib68]). Chloride concentration values thus span a wide range and yet, in each compartment, it is quite tightly regulated ([@bib69]). For example, in early endosomes it is \~40 mM, late endosomes it is \~70 mM and lysosomes it is \~108 mM ([@bib30]; [@bib60]; [@bib68]). Chloride levels are stringently regulated by chloride channels such as cystic fibrosis transmembrane regulator (CFTR), the CLC family of channels or calcium activated chloride channels, and their dysregulation is directly linked to several diseases including cystic fibrosis, myotonia, epilepsy, hyperekplexia or deafness ([@bib54]). Chloride is largely considered to function as a counter ion only to balance changes in cation fluxes related to signaling ([@bib64]). In one form, this balancing function serves to reset the membrane potential of depolarized neurons through the operation of plasma membrane resident chloride channels/exchangers ([@bib13]). In another form, it serves to continuously facilitate organelle acidification, through the operation of intracellular chloride channels ([@bib70]). Despite its importance in cell function, intracellular chloride has never been visualized or quantitated *in vivo*.

DNA nanotechnology has offered creative, functional imaging solutions to quantitate second messengers as well as image organelles in real time in living cells and in genetic model organisms ([@bib9]; [@bib12]; [@bib43]; [@bib73]). Here, using a previously developed, pH-independent, DNA-based fluorescent chloride reporter called *Clensor*, we have made the first measure of chloride in a live multicellular organism, creating *in vivo* chloride maps of lysosomes in *C. elegans*.

Our investigations reveal that lysosomal chloride levels *in vivo* are even higher than extracellular chloride levels. Others and we have shown that lysosomes have the highest lumenal acidity and the highest lumenal chloride , among all endocytic organelles ([@bib60]; [@bib80]). Although lumenal acidity has been shown to be critical to the degradative function of the lysosome ([@bib3]; [@bib20]), the necessity for such high lysosomal chloride is unknown. In fact, in many lysosomal storage disorders, lumenal hypoacidification compromises the degradative function of the lysosome leading to the toxic build-up of cellular cargo targeted to the lysosome for removal, resulting in lethality ([@bib28]). Lysosomal storage disorders (LSDs) are a diverse collection of \~70 different rare, genetic diseases that arise due to dysfunctional lysosomes ([@bib61]). Dysfunction in turn arises from mutations that compromise protein transport into the lysosome, the function of lysosomal enzymes, or lysosomal membrane integrity ([@bib23]). Importantly, for a sub-set of lysosomal disorders like osteopetrosis or neuronal ceroid lipofuscinoses (NCL), lysosomal hypoacidification is not observed ([@bib39]). Both these conditions result from a loss of function of the lysosomal H^+^-Cl^-^ exchange transporter CLC-7 ([@bib39]). In both mice and flies, lysosomal pH is normal, yet both mice and flies were badly affected ([@bib56]; [@bib80]).

The lysosome performs multiple functions due to its highly fusogenic nature. It fuses with the plasma membrane to bring about plasma membrane repair as well as lysosomal exocytosis, it fuses with the autophagosome to bring about autophagy, it is involved in nutrient sensing and it fuses with endocytic cargo to bring about cargo degradation ([@bib3]; [@bib82]). To understand which, if any, of these functions is affected by chloride dysregulation, we chose to study genes related to osteopetrosis in the versatile genetic model organism *Caenorhabditis elegans*. By leveraging the DNA scaffold of *Clensor* as a natural substrate along with its ability to quantitate chloride, we could simultaneously probe the degradative capacity of the lysosome *in vivo* and then in cultured mammalian cells. Our findings reveal that depleting lysosomal chloride showed a direct correlation with loss of the degradative function of the lysosome. We found that lowering lysosomal chloride also reduced the level of Ca^2+^ released from the lysosome. We also observed that reduction of lysosomal chloride inhibited the activity of specific lysosomal enzymes such as cathepsin C and arylsulfatase B. The role of chloride in defective lysosomal degradation has been hypothesized in the past ([@bib70]; [@bib79]; [@bib78]), and our studies provide the first mechanistic proof of a broader role for chloride in lysosome function.

Results and discussion {#s2}
======================

Reporter design and uptake pathway in coelomocytes of *C. elegans* {#s2-1}
------------------------------------------------------------------

In this study we use two DNA nanodevices, called the I-switch and *Clensor*, to fluorescently quantitate pH and chloride respectively ([@bib51]; [@bib60]). The I-switch is composed of two DNA oligonucleotides. One of these can form an i-motif, which is an unusual DNA structure formed by protonated cytosines ([@bib24]). In the I-switch, intrastrand i-motif formation is used to bring about a pH-dependent conformational change, that leverages fluorescence resonance energy transfer (FRET) to create a ratiometric fluorescent pH reporter. ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"})

The DNA-based chloride sensor, *Clensor,* is composed of three modules: a sensing module, a normalizing module and a targeting module ([Figure 1a](#fig1){ref-type="fig"}) ([@bib60]; [@bib57]). The sensing module is a 12 base long peptide nucleic acid (PNA) oligomer conjugated to a fluorescent, chloride-sensitive molecule 10,10′-Bis\[3-carboxypropyl\]−9,9′-biacridinium dinitrate (BAC), ([Figure 1a](#fig1){ref-type="fig"}) ([@bib68]). The normalizing module is a 38 nt DNA sequence bearing an Alexa 647 fluorophore that is insensitive to Clˉ. The targeting module is a 26 nt double stranded DNA domain that targets it to the lysosome via the endolysosomal pathway by engaging the scavenger receptor or ALBR pathway. In physiological environments, BAC specifically undergoes collisional quenching by Clˉ, thus lowering its fluorescence intensity (G) linearly with increasing Clˉ concentrations. In contrast, the fluorescence intensity of Alexa 647 (R) remains constant ([Figure 1b](#fig1){ref-type="fig"}). This results in R/G ratios of *Clensor* emission intensities varying linearly with \[Clˉ\] over the entire physiological regime of \[Clˉ\]. Since the response of *Clensor* is insensitive to pH changes, it enables the quantitation of lumenal chloride in organelles of living cells regardless of their lumenal pH ([@bib60]).10.7554/eLife.28862.003Figure 1.*Clensor* recapitulates its chloride sensing characteristics *in vivo*.(**a**) Schematic of the ratiometric, fluorescent chloride (Clˉ) reporter *Clensor*. It bears a Clˉ sensitive fluorophore, BAC (green star) and a Clˉ insensitive fluorophore, Alexa 647 (red circle) (**b**) Calibration profile of *Clensor in vitro* (grey) and *in vivo* (red) given by normalized Alexa 647 (**R**) and BAC (**G**) intensity ratios versus \[Cl^-^\]. (**c**) Receptor mediated endocytic uptake of *Clensor* in coelomocytes post injection in *C. elegans.* (**d**) *Clensor* is trafficked by the anionic ligand binding receptor (ALBR) from the early endosome (EE) to the late endosome (LE) and then lysosome (LY). (**e**) Colocalization of *Clensor~A647~* (red channel) microinjected in the pseudocoelom with GFP-labeled coelomocytes (green channel). Scale bar: 5 μm. (**f**) Representative fluorescence images of endosomes in coelomocytes labeled with *Clensor* and clamped at the indicated Clˉ concentrations (\[Cl^-^\]). Images are acquired in the Alexa 647 (**R**) and BAC (**G**) channels from which corresponding pseudocolored R/G images are generated. The *in vivo* calibration profile is shown in (**b**). Scale bar: 5 µm. Error bars indicate s.e.m. (n = 15 cells,≥50 endosomes) (**g**) *In vitro* (grey) and *in vivo* (red) fold change in R/G ratios of *Clensor* from 5 mM to 80 mM \[Clˉ\].**DOI:** [http://dx.doi.org/10.7554/eLife.28862.003](10.7554/eLife.28862.003)10.7554/eLife.28862.004Figure 1---figure supplement 1.(**a**) Quantification of co-localization between DNA nanodevices and GFP in *arIs37* worms.Mean of n = 10 cells. (**b**) Coelomocyte labeling efficiency with *I-switch* (I4~A647~, grey) and *Clensor~A647~* (red) in the absence (-mBSA) or presence of 150 or 300 equivalents excess of maleylated bovine serum albumin (mBSA). Error bars indicate s.e.m. (n = 10 worms) (**c**) Images showing colocalization of *I-switch* (red) 1 hr post injection in the pseudocoelom of *arIs37* \[pmyo-3::ssGFP\] worms (green). Scale bar: 5 μm. (**d**) RT-PCR analysis of total RNA isolated from *C. elegans* pre- and post- RNAi. Lanes correspond to PCR-amplified cDNA of the indicated gene product isolated from wild type without RNAi treatment (denoted by gene name) and the corresponding dsRNA-fed worms (denoted as. '**---** ncr-1', '**---** chl-6' etc).**DOI:** [http://dx.doi.org/10.7554/eLife.28862.004](10.7554/eLife.28862.004)10.7554/eLife.28862.005Figure 1---figure supplement 2.(**a**) Schematic of a DNA nanodevice, *I-switch*, that functions as a fluorescent pH reporter based on a pH triggered conformational change that is transduced to photonic changes driven by differential fluorescent resonance energy transfer between donor (D, green) and acceptor (A, red) fluorophores (**b**) pH calibration curve of I4^cLY^~A488/A647~ *in vivo* (red) and *in vitro* (grey) showing normalized D/A ratios versus pH.Error bars indicate s.e.m. (n = 15 cells, ≥60 endosomes) (**c**) *in vitro* (grey) and *in vivo* (red) fold change in D/A ratios of I4^cLY^~A488/A647~ from pH 4.0 to pH 7.5. (**d**) Representative images of coelomocytes labelled with I4^cLY^~A488/A647~, clamped at the indicated pH. Images are acquired in donor channel (**D**), acceptor channel (**A**) from which the respective pseudocolored D/A image is obtained. Scale bar, 5 μm. (**e**) Histograms showing typical spread of D/A ratios of endosomes clamped at pH 4 (lavender) and pH 7.5 (salmon);(*n* = 10 cells, ≥100 endosomes). We use the I switch for pH measurements in the lysosomes of coelomocytes ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We first validate the sensor *in vivo*. For this we first generate an *in vivo* calibration profile for the sensor using previous methods standardized by our lab ([@bib71]). Briefly worms are injected with 500 nM I-switch and were placed in clamping buffers of varying pH 1 hr post injection. Post 75 mins incubation, worms were imaged in the Donor Channel (**D**) and Acceptor Channel (**A**) ([Figure 1---figure supplement 2d](#fig1s2){ref-type="fig"}). On plotting the mean D/A against varying pH we generate a calibration curve which shows that the sensor's *in vivo* performance is similar to the *in vitro* profile ([Figure 1---figure supplement 2b and c](#fig1s2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.28862.005](10.7554/eLife.28862.005)10.7554/eLife.28862.006Figure 1---figure supplement 3.Selectivity of *Clensor* (200 nM) in terms of its fold change in R/G from \~0 to 100 mM of each indicated anion unless otherwise indicated.(\*\* \~ 0 to 10 mM). Since Cl^−^ channels are known to exhibit poor anion selectivity, we investigate the selectivity of *Clensor* to demonstrate the signal change in cell is attributed by the change of chloride ions level. The selectivity of *Clensor* to various anions in the form of their sodium salts. This reveals that the sensitivity of *Clensor* to diverse biologically abundant anions including NO~3~^-^ and PO~4~^3-^ is negligible.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.006](10.7554/eLife.28862.006)

Targeting *Clensor* to lysosomes of coelomocytes in *C. elegans* {#s2-2}
----------------------------------------------------------------

Coelomocytes of *C. elegans* are known to endocytose foreign substances injected in the body cavity ([@bib21]). The polyanionic phosphate backbone of DNA can be co-opted to target it to scavenger receptors and thereby label organelles on the endolysosomal pathway in tissue macrophages and coelomocytes in *C. elegans* ([Figure 1c and d](#fig1){ref-type="fig"}) ([@bib10]; [@bib51]; [@bib60]; [@bib71]). Alexa 647 labelled I-switch (I4^cLY^) and *Clensor* were each injected in the pseudocoelom of 1-day-old adult worms expressing *pmyo-3*::ssGFP. In these worms, soluble GFP synthesized in muscles and secreted into the pseudocoelom is actively internalized by the coelomocytes resulting in GFP labeling of the coelomocytes ([@bib21]). After 1 hr, both devices quantitatively colocalize with GFP indicating that they specifically mark endosomes in coelomocytes ([Figure 1e](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1c](#fig1s1){ref-type="fig"}). Endocytic uptake of DNA nanodevices was performed in the presence of 30 equivalents of maleylated bovine serum albumin (mBSA), a well-known competitor for the anionic ligand binding receptor (ALBR) pathway ([@bib25]). Coelomocyte labeling by I4^cLY^or *Clensor* were both efficiently competed out by mBSA indicating that both reporters were internalized by ALBRs and trafficked along the endolysosomal pathway ([Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"}) ([@bib71]).

*In vivo* performance of DNA reporters {#s2-3}
--------------------------------------

Next, the functionality of I4^cLY^ and *Clensor* were assessed *in vivo*. To generate an *in vivo* calibration curve for the I-switch I4^cLY^, coelomocytes labeled with I4^cLY^ were clamped at various pH values between pH 4 and 7.5 as described previously and in the supporting information ([@bib71]). This indicated that, as expected, the I-switch showed *in vitro* and *in vivo* performance characteristics that were extremely well matched ([Figure 1---figure supplement 2b--e](#fig1s2){ref-type="fig"}). To assess the *in vivo* functionality of *Clensor*, a standard Clˉ calibration profile was generated by clamping the lumenal \[Clˉ\] to that of an externally added buffer containing known \[Clˉ\] as described previously for cultured cells ([@bib60]). Endosomes of coelomocytes were labeled with *Clensor* and fluorescence images were acquired in the BAC channel (G) as well as Alexa 647 channel (R) as described (see Materials and methods), from which were obtained R/G ratios of every endosome clamped at a specific \[Clˉ\] ([Figure 1b](#fig1){ref-type="fig"}). Endosomal R/G ratios showed a linear dependence on \[Clˉ\] with \~2 fold change in R/G values from 5 mM to 80 mM \[Clˉ\] ([Figure 1f and g](#fig1){ref-type="fig"}). This is very well matched with its *in vitro* fold change in R/G over the same regime of \[Clˉ\].

DNA nanodevices localize specifically in lysosomes in diverse genetic backgrounds {#s2-4}
---------------------------------------------------------------------------------

Before performing quantitative chloride imaging in various mutant nematodes, we checked whether lysosomal targeting of *Clensor* and the I-switch were preserved in a variety of genetic backgrounds of our interest. *Clensor* was injected into LMP-1::GFP worms treated with RNAi against specific lysosomal storage disorder (LSD)-related genes or genes linked to osteopetrosis. We observed significant colocalization (\>74%) of *Clensor* with LMP-1-GFP labeled lysosomes in these coelomocytes ([Figure 3---figure supplement 2b and c](#fig3s2){ref-type="fig"}). Given that both *Clensor* and the I-switch robustly labeled lysosomes of coelomocytes in wild type worms (N2), mutants and RNAi knockdowns of a range of LSD-related genes, we explored whether these devices could report on alterations, if any, in the lumenal ionicity in these lysosomes, and thereby possibly report on lysosome dysfunction.

Quantitative *in vivo* imaging of chloride in lysosomes in *C. elegans* {#s2-5}
-----------------------------------------------------------------------

As an initial study, we focused on *C. elegans* nematodes in which genes related to osteopetrosis are mutated. Osteopetrosis results from non-functional osteoclasts that lead to increased bone mass and density due to a failure in bone resorption ([@bib67]). In humans, osteopetrosis results from mutations in a lysosomal chloride-proton antiporter CLCN7, and its auxiliary factor OSTM1 ([Figure 2a](#fig2){ref-type="fig"}) ([@bib40]; [@bib44]). It also results from mutations in TCIRG1, which is the a3 subunit of a lysosomal V-ATPase ([@bib41]) and SNX-10, a sorting nexin implicated in lysosome transport to form the ruffled border of osteoclasts, which is critical for osteoclast function ([@bib1]) ([Figure 2a](#fig2){ref-type="fig"}). Lysosomes of CLC7 knockout mice show normal lumenal pH, yet the mice manifest osteopetrosis as well as neurodegeneration, indicating that despite the apparently normal lumenal milieu, the organelle is still dysfunctional ([@bib39]). The *C. elegans* homologs for these genes are *clh-6* (CLCN7), *F42A8.3* (*ostm-1*; OSTM1), *unc-32* (TCIRG1) and *snx-3* (SNX10) ([Figure 2a](#fig2){ref-type="fig"}).10.7554/eLife.28862.007Figure 2.Dysregulation in lysosomal \[Cl^-^\] correlates with reduced lysosomal degradation.(**a**) Schematic depicting protein players involved in autosomal recessive osteopetrosis. (**b**) Representative images of *Clensor* in lysosomes of coelomocytes, in the indicated genetic backgrounds acquired in the Alexa 647 (R) and BAC (G) channels and their corresponding pseudocolored R/G images. Scale bar, 5 μm. (**c**) Lysosomal Cl^-^ concentrations (\[Cl^-^\]) measured using *Clensor* in indicated genetic background (n = 10 worms, ≥100 lysosomes). (**d**) Degradative capacity of lysosomes of coelomocytes in nematodes with the indicated genetic backgrounds as given by the observed half-life of *Clensor*. Error bars indicate s.e.m.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.007](10.7554/eLife.28862.007)10.7554/eLife.28862.008Figure 2---figure supplement 1.(**a**) Representative images of coelomocyte lysosomes labeled with *Clensor* one hour post injection, in the indicated genetic backgrounds acquired in the Alexa 647 (R) and BAC (G) channels and the corresponding pseudocolored R/G images.Scale bar, 5 μm. (**b**) Histograms comparing the spread of R/G in coelomocytes in different RNAi background. (n = 10 cells; \>100 lysosomes). (**c**) Lysosomal pH measured using I4^cLY^~A488/A647~ in the indicated genetic backgrounds (n = 10 worms, ≥100 lysosomes). [Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"} shows representative images of chloride measurements in lysosomes of coelomocytes of worms where various genes related to osteopetrosis are either knocked out or knocked downs. [Figure 2---figure supplement 1b](#fig2s1){ref-type="fig"} shows a histogram comparing the spread of R/G values reporting lysosomal chloride in the indicated genetic backgrounds. We observe that the R/G values are lower in the case of *clh-6* mutant and *ostm-1* RNAi whereas that of *snx-3* is similar to wild type.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.008](10.7554/eLife.28862.008)10.7554/eLife.28862.009Figure 2---figure supplement 2.(**a**) Plots showing mean whole cell intensity of *I4*~A647~ per coelomocyte, as a function of time, post-injection in indicated genetic backgrounds.Error bars indicate s.e.m. (n ≥ 10 cells). (**b**) Schematic depicting protein players involved in autosomal recessive osteopetrosis. Also shown is clh-4, a plasma membrane resident chloride channel, that is used as a control. The above figure shows the stability of I switch in the lysosomes of the coelomocytes. Worms were injected with *I4*~A647~ and the number of labeled coelomocytes were plotted as a function of time. This gives an exponential decay profile, with progressively more coelomocytes losing their labeling as the DNA device is degraded in the coelomocyte. An exponential is fitted that gives the half-life of the device. In N2 worms, the half-life of the DNA reporters is \~6.5 hr, with maximal labelling occurring at 2 hr post injection.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.009](10.7554/eLife.28862.009)

*Clensor* was injected into N2, *clh-6* and *unc-32* mutants and RNAi knockdowns of *ostm-1* and *snx-3*. Chloride concentrations in the lysosomes of each genetic background at 60 min post injection were obtained ([Figure 2b,c](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). N2 worms showed a chloride concentration of \~75 mM. Knocking down *clh-6* and *ostm-1* resulted in a dramatic decrease of lysosomal chloride to \~45 mM due to the loss of function in chloride transport. Lumenal pH in the lysosomes of these mutants was normal, consistent with findings in both flies and mice ([@bib60]; [@bib80]). As a control, knocking down a plasma membrane resident CLC channel such as *clh-4* showed no effect on either lysosomal chloride or pH ([@bib62]). *unc-32c* is a non-functional mutant of the V-ATPase *a* sub-unit, while *unc-32f* is a hypomorph ([@bib58]). Interestingly, a clear inverse correlation with *unc-32* functionality was obtained when comparing their lysosomal chloride levels i.e.,\~55 mM and \~65 mM for *unc-32c* and *unc-32f* respectively. Importantly, *snx-3* knockdowns showed lysosomal chloride levels that mirrored those of wild type lysosomes. In all genetic backgrounds, we observed that lysosomal chloride concentrations showed no correlation with lysosome morphology ([Figure 3---figure supplement 1d](#fig3s1){ref-type="fig"}).

Reducing lumenal chloride lowers the degradative capacity of the lysosome {#s2-6}
-------------------------------------------------------------------------

Dead and necrotic bone cells release their endogenous chromatin extracellularly - thus duplex DNA constitutes cellular debris and is physiologically relevant cargo for degradation in the lysosome of phagocytic cells ([@bib19]; [@bib46]). Coelomocytes are phagocytic cells of *C. elegans*, and thus, the half-life of *Clensor* or I4^cLY^ in these cells constitutes a direct measure of the degradative capacity of the lysosome ([@bib74]). We used a previously established assay to measure the half-life of I-switches in lysosomes ([@bib72]). Worms were injected with 500 nM I4^cLY^ and the fluorescence intensity obtained in 10 cells at each indicated time point was quantitated as a function of time. The I-switch I4^cLY^ had a half-life of \~6 hr in normal lysosomes, which nearly doubled when either *clh-6* or *ostm-1* were knocked down ([Figure 2d](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Both *unc-32c* and *unc-32f* mutants showed near-normal lysosome degradation capacity, inversely correlated with their lysosomal chloride values ([Figure 2d](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

In this context, data from *snx-3* and *unc-32f* mutants support that high lysosomal chloride is critical to the degradation function of the lysosome. In humans, SNX10 is thought to be responsible for the vesicular sorting of V-ATPase from the Golgi or for its targeting to the ruffled border ([@bib1]). Non-functional SNX10 can thus be considered a \'secondary V-ATPase deficiency\', phenocopying a V-ATPase deficiency and showing osteoclasts without ruffled borders due to defective lysosomal transport ([@bib1]). Importantly, lysosomal pH in *snx-3* knockdowns was compromised by 0.3 pH units, while that in *unc-32* knockdowns was compromised by 0.2 pH units ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) ([@bib14]). Yet both these genetic backgrounds showed completely normal lysosomal degradation capacity, that is consistent with their normal lumenal chloride levels, rather than their defective pH levels. This further supports that high lysosomal chloride is a sensitive correlate of the degradative function of the lysosome.

Lysosomal chloride is highly depleted in lysosomal storage disorders {#s2-7}
--------------------------------------------------------------------

Since lysosomal chloride dysregulation correlated with a loss of degradative ability of the lysosome, we wondered whether the converse was true, i.e., whether lysosomes known to be defective in degradation as seen in lysosomal storage disorders, showed depleted chloride levels. Given that in higher organisms such as mice and humans, high acidity has also been shown to be essential for proper lysosome function ([@bib50]), we measured both lysosomal pH and lysosomal chloride in *C. elegans* mutants and RNAi knockdowns for a range of genes that are known to cause lysosomal storage disorders. These included a selection of diseases due to dysfunctional enzymes that metabolize sugar derivatives, such as mannose and glycosaminoglycans, as well as lipids such as sphingomyelin and glucosylceramide. Lysosomal pH and chloride measurements were made with I4^cLY^ and *Clensor* respectively, in each genetic background at 60 min post injection ([Figure 3a and b](#fig3){ref-type="fig"}). We found that in *C. elegans* mutants for Gaucher's disease, Batten disease, different forms of NCL, MPS VI and Niemann Pick A/B disease, lysosomal chloride levels were severely compromised ([Figure 3a and b](#fig3){ref-type="fig"}). Dysfunctional lysosomes showed three types of ion profiles, those where either lysosomal acidity or chloride levels were reduced, and those where both lysosomal acidity and chloride were reduced. The magnitude of proton dysregulation in these defective lysosomes ranged between 1.9--2.8 µM. However, the magnitude of lysosomal chloride showed a stark drop, decreasing by 19--34 mM in most mutants. Importantly, in mammalian cell culture models for many of these diseases example for Gaucher\'s disease, NCL, MPS VI, etc., only pH dysregulation has been reported ([@bib6]; [@bib34]; [@bib66]). Yet we find that in *C. elegans* models of these diseases that chloride levels are highly compromised. Chloride decreases by nearly three orders of magnitude more than proton decrease, and the percentage changes of both ions are similar.10.7554/eLife.28862.010Figure 3.Lysosomal chloride dysregulation is observed in nematode models in several pH-related lysosomal storage disorders.(**a**) Representative pH maps of lysosomes in coelomocytes labelled with a DNA-based pH reporter, I4^cLY^~A488/A647~, in the indicated genetic backgrounds. Images were acquired in the donor (D, magenta) and acceptor (A, cyan) channels and the corresponding pseudocolored D/A images. Scale bar, 5 μm (**b**) Representative \[Cl^-^\] maps of lysosomes acquired in these genetic backgrounds using *Clensor*. Images are acquired in the Alexa 647 (R) and BAC (G) channels and the corresponding pseudocolored R/G images are shown. Scale bar, 5 μm. (**c**) Quantification of lysosomal pH and lysosomal Cl^-^ in *C. elegans* mutants or RNAi knockdowns of genes responsible for the indicated lysosomal storage diseases in humans. Mutants are grouped according to dysregulation only in lysosomal pH (purple box); only in lysosomal chloride (green box) and both lysosomal pH and chloride (pink box) for n = 10 worms (≥100 lysosomes) Error bars indicate s.e.m.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.010](10.7554/eLife.28862.010)10.7554/eLife.28862.011Figure 3---figure supplement 1.(**a**) Representative images of LMP-1::GFP marked coelomocytes in the background of indicated RNAi.Scale bar: 5 μm. (**b**) Histograms comparing the spread in size of LMP-1::GFP positive vesicles in coelomocytes in the indicated RNAi background (n = 20 cells). (**c**) D/A values obtained for individual pH measurements in lysosomes as a function of area of each vesicle in the indicated genetic background. The linear regression is shown in red. The coefficient of regression (p = ‒0.14) shows no correlation (n \> 100 lysosomes). (**d**) R/G values obtained for individual Cl^-^ measurement in lysosomes as a function of area of each vesicle in the indicated genetic background. The linear regression line is shown in red. The coefficient of regression (p= ‒0.18) shows no correlation (n \> 100 lysosomes). A key phenotype observed in cells derived from patients suffering from lysosomal storage disorders (LSD) is the presence of enlarged lysosomes ([@bib22]; [@bib55]). LSD-related gene knockdowns in worms show subtle to no observable whole organismal phenotypes ([@bib18]). However, on knocking down various LSD-related genes in the background of LMP-1::GFP worms we observed that the morphology of LMP-1 positive vesicles were altered and that the coelomocytes contained enlarged lysosomes, some as large as eight microns in diameter ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). [Figure 3---figure supplement 1b](#fig3s1){ref-type="fig"} represents a plot of the diameter distribution for LMP-1 positive vesicles under each indicated genetic background. Worms with LSD-related gene knockdowns show a broader distribution of vesicle sizes compared to a more tightly regulated size distribution in wild type nematodes or non-LSD related mutants. example for when *clh-4*, a plasma membrane resident chloride channel was knocked down, lysosomal morphology is not affected. We carried out pH and chloride measurements for worms from various genetic backgrounds and checked for correlations between lysosomal D/A (or R/G) and lysosome size. On plotting D/A values obtained from pH measurements in *ncr-1* RNAi worms, against the area of each vesicle; we observe no correlation between the two parameters ([Figure 3---figure supplement 1c](#fig3s1){ref-type="fig"}). A similar observation is seen in the case of chloride R/G measurements ([Figure 3---figure supplement 1d](#fig3s1){ref-type="fig"}). Thus assaying only for lysosome size shows no correlation with lysosome functionality. However lumenal chloride concentration is the best correlate of lysosome dysfunction, irrespective of size.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.011](10.7554/eLife.28862.011)10.7554/eLife.28862.012Figure 3---figure supplement 2.(**a**) Worms expressing LMP-1::GFP in coelomocytes were injected with I4^cLY^~A647~ or *Clensor*~A647~ (red) and show maximal colocalization with LMP-1::GFP vesicles (green) at 60 min.Scale bar: 5 μm (**b**) Representative images of worms expressing LMP-1::GFP (green) in the background of various indicated RNAi\'s, which were injected with *Clensor*~A647~ (red) and imaged 60 mins post-injection. Scale bar: 5 μm. (**c**) Quantification of colocalization between the *Clensor*~A647~ and GFP in *arIs37* worms. Mean of n = 10 cells. To check whether our DNA nanodevices can mark the lysosomes of coelomocytes in wild type worms, we injected 500 nM of I4^cLY^~A647~ or *Clensor~A647~* into worms containing LMP1::GFP marker ([Figure 3---figure supplement 2a](#fig3s2){ref-type="fig"}). The worms were imaged 1 hr post injection in the GFP channel (green) and in Alexa 647 channel (red) to visualize the lysosomal marker and DNA reporter respectively. Merged images show colocalization of DNA devices with the lysosomal marker, similar to previous studies ([@bib71]). We then proceeded to validate the devices in the lysosomes in coelomocytes of various LSD-related genes knocked down worms. LMP1::GFP positive worms that were RNAi-ed for indicated genes were injected with *Clensor~A647~* and imaged 1 hr post injection ([Figure 3---figure supplement 2b](#fig3s2){ref-type="fig"}). We observe that, in worms, *Clensor* reliably marks the lysosomes in all LSD- related gene knockdowns with over 74% colocalization ([Figure 3---figure supplement 2c](#fig3s2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.28862.012](10.7554/eLife.28862.012)10.7554/eLife.28862.013Figure 3---figure supplement 3.(**a**) Histograms comparing the spread of D/A in coelomocytes in different RNAi background.(n = 10 cells; \>100 lysosomes). (**b**) Histograms comparing the spread of R/G in coelomocytes in different RNAi background. (n = 10 cells; \>100 lysosomes).**DOI:** [http://dx.doi.org/10.7554/eLife.28862.013](10.7554/eLife.28862.013)

To check whether such chloride decrease is observed also in higher organisms, we made pH and chloride measurements in mammalian cell culture models of two relatively common lysosomal storage disorders. Macrophages are a convenient cell culture system to study lysosomal storage disorders as they can be isolated from blood samples and have a lifetime of 3 weeks in culture ([@bib77]). We re-created two widely used murine and human cell culture models of Gaucher's disease by inhibiting β-glucosidase with its well-known inhibitor conduritol β epoxide (CBE) in murine and human macrophages namely, J774A.1 and THP-1 cells respectively ([@bib31], [@bib32]; [@bib63]). We also recreated common mammalian cell culture models of Niemann-Pick A/B disease by inhibiting acid sphinogomyelinase (SMPD1) in J774A.1 and THP-1 cells with a widely used inhibitor amitriptyline hydrochloride (AH) ([@bib2]; [@bib37]). First we confirmed that *Clensor* and our DNA-based pH reporter localized exclusively in lysosomes. In both cell lines, DNA nanodevices (500 nM) were uptaken from the extracellular milieu by the scavenger receptors, followed the endolysosomal pathway and showed quantitative colocalization with lysosomes that were pre-labelled with TMR-Dextran ([Figure 4---figure supplement 3a and b](#fig4s3){ref-type="fig"}). In-cell calibration curves of both pH ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) and chloride reporters ([Figure 4a](#fig4){ref-type="fig"}) were well matched with their *in vitro* calibration profiles, indicating that both sensor integrity and performance were quantitatively preserved at the time of making lysosomal pH and chloride measurements in these cells. Both human and murine lysosomes in normal macrophages showed chloride concentrations close to \~118 mM, revealing that lysosomes have the highest chloride levels compared to any other endocytic organelle ([@bib60]; [@bib68]). This is nearly 10--15% higher than even extracellular chloride concentrations, which reaches only up to 105--110 mM ([@bib4]).10.7554/eLife.28862.014Figure 4.Lysosomal chloride is substantially depleted in mammalian cell culture models of lysosomal storage diseases.(**a**) Calibration profile of *Clensor* in cells (red) and *in vitro* (grey) showing normalized Alexa 647 (R) and BAC (G) intensity (R/G) ratios versus \[Cl^-^\]. Error bars indicate s.e.m. (n = 20 cells,≥100 endosomes) (**b**) Fold change in R/G ratios of *Clensor in vitro* (grey) and in cells (red) from 5 mM to 120 mM \[Clˉ\] (**c**) Representative \[Cl^-^\] maps of *Clensor* in lysosomes of J774A.1 cells treated with the indicated lysosomal enzyme inhibitor. Images of the Alexa 647 (R) channel and pseudocolored R/G images are shown. Scalebar: 10 μm. (**d**) Bar graphs of lysosomal Cl^-^ values obtained in THP-1 and J774A.1 cells treated with the indicated inhibitors. NPPB (50 μM), Amitryptiline, AH (10 μM), Conduritol β-epoxide, CBE (400 μM) were used to model Niemann Pick A/B and Gaucher\'s diseases in both cell types. Error bars indicate s.e.m. (n = 10 cells, ≥60 endosomes). (**e**) Bar graphs of lysosomal pH values obtained in THP-1 and J774A.1 cells treated with the indicated inhibitors. NPPB (50 μM), Amitryptiline, AH (10 μM), Conduritol β-epoxide, CBE (400 μM) were used to model Niemann Pick A/B and Gaucher\'s diseases respectively in both cell types. Error bars indicate s.e.m. (n = 10 cells, ≥50 endosomes).**DOI:** [http://dx.doi.org/10.7554/eLife.28862.014](10.7554/eLife.28862.014)10.7554/eLife.28862.015Figure 4---figure supplement 1.(**a**) Structure of Oregon Green (OG) and schematic of I^mLy^ (**b**) Fluorescence emission spectra of I^mLy^ at the indicated pH obtained using λ~Ex~OG = 494 nm (green) and λ~Ex~ Atto 647N = 650 nm (red).(**c**) Representative 12% denaturing PAGE stained with Ethidium bromide (EtBr) showing conjugation of OG (green) to thiol labelled DNA (purple arrow) imaged in the ETBr and OG channels respectively (**d**) Representative 20% PAGE showing formation of I^mLy^ (**e**) pH calibration curve of I^mLy^ *in cellulo* (red) and *in vitro* (black) showing normalized G/R ratios versus pH. Error bars indicate s.e.m. (n = 15 cells, ≥60 endosomes) (**f**) *in vitro* and *in* *cellulo *fold change in G/R ratios of I^mLy^ from 3.5 to pH 6.4. To create a pH sensor for mammalian lysosomes we conjugated a pH sensitive dye ‒ Oregon green (OG) which pKa is 4.9 (green chemical structure) to thiol labelled DNA using a maleimide linker (blue chemical structure). The complementary strand contains a normalizing dye, Atto 647N (red circle). The conjugation of OG was confirmed by 12% denaturing PAGE ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Furthermore, the formation of I^mLy^ was confirmed by a gel mobility shift assay using native polyacrylamide gel electrophoresis. We annealed 10 μM of both components in equimolar ratios in 10 mM sodium phosphate buffer, pH 7.4 and investigated the sample by PAGE. The formation of I^mLy^ was revealed by its lower electrophoretic mobility with respect to its component single strands ([Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}). The fluorescence of OG increases with the pH while the fluorescence of normalizing dye Atto 647N remains unchanged ([Figure 4---figure supplement 1b](#fig4s1){ref-type="fig"}). Furthermore, the *in cellulo* calibration were well matched with their *in vitro* calibration profiles ([Figure 4---figure supplement 1e‒f](#fig4s1){ref-type="fig"}), indicating that both sensor integrity and performance were quantitatively preserved at the time of making lysosomal pH a measurements in these cells.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.015](10.7554/eLife.28862.015)10.7554/eLife.28862.016Figure 4---figure supplement 2.Plots showing mean whole cell intensity (wci, black line) of *Clensor*~A647~ in cells imaged as a function of indicated times in (**a**) J774A.1 cells and (**b**) THP-1 cells.Blue lines show wci traces of individual cells as a function of time. Error bars indicate s.e.m. (n ≥ 25 cells). Representative images of (c) J774A.1 cells and (d) THP-1 cells at indicated time points. Scale bar: 10 µm. To examine the stability of *Clensor in cellulo*, we pulse 500 nM *Clensor* for 30 min and chase for other 60 min to J774A.1 cells and THP-1 cells. The whole cell intensity of *Clensor*~A647~ was unchanged upon 60 min chasing and decrease significantly from 60 min to 90 min for J774A.1 cell while no significant change was observed for THP-1 cells. The result indicates that the DNA device is stable for lysosomal pH measurement using our protocol (30 min pulse follow by 60 min chasing).**DOI:** [http://dx.doi.org/10.7554/eLife.28862.016](10.7554/eLife.28862.016)10.7554/eLife.28862.017Figure 4---figure supplement 3.(**a**) Representative images showing colocalization of I^mLy^~AT647~ with TMR-Dex in J774A.1 and THP-1 macrophages (**b**) Macrophage labeling efficiency with *Clensor~A647~* (A647) in the absence or presence of 50 equivalents excess of maleylated bovine serum albumin (mBSA) in comparison to TMR Dextran.Error bars indicate s.e.m. (n = 20 cells). To verify whether I^mLy^ was endocytosized to lysosome by anionic ligand binding receptor (ALBR) pathyway, cells were first pre-labelled with TMR-Dextran a marker of lysosome through fluid phase (0.5 mg/mL; 1 hr pulse followed by 16 hr chase). Cells were then pulse I^mLy^ for 30 min and chased for 60 min. Co-localization of I^mLy^ with TMR-Dextran was observed. Next, competition experiments with 30 equivalents of maleylated BSA (mBSA) ‒ a well-known competitor for the anionic ligand, were performed. In the presence of mBSA, only the intensity of I^mLy^ was decreased significantly thus confirming that I^mLy^ was endocytosized *via* ALBR pathway.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.017](10.7554/eLife.28862.017)10.7554/eLife.28862.018Figure 4---figure supplement 4.Co-localization of *Clensor* (red) with lysosomes labelled with TMR--dextran (green) in J774A.1 cells treated with the indicated lysosomal enzyme inhibitors.(**a**) Representative images of lysosomes of J774A.1 cells labelled with TMR dextran (TMR; **G**) and *Clensor* (Alexa 647; **R**) in the absence of any inhibitor, 50 μM NPPB, 10 μM Amitryptiline hydrochloride (AH) 400 μM of Conduritol β-epoxide (CBE) or 10 μM of U18666A . Scale bar, 5 μm (b) Pearson\'s correlation coefficient for the colocalization between *Clensor* and TMR Dextran. To eliminate the possibility that trafficking defect in LSD may contributes to the observed reduction in lysosomal \[Cl^-^\]. We pre-labelled lysosomes with TMR-Dextran (0.5 mg/mL) using literature protocols, treated cells with U18666A and Conduritol β-epoxide (CBE) to induce Niemann Pick C and Gaucher\'s cellular phenotype respectively, only then pulse *Clensor* for 30 min, chased for 60 min, and scored for co-localization with TMR-Dextran. Amitriptyline (AH) and NPPB were added 30 min after the pulsing and chasing of *Clensor* to the lysosome. We observed that *Clensor* colocalized with lysosomes under each of these conditions, indicating that they do not suffer trafficking defects in these cell culture models of lysosomal storage diseases.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.018](10.7554/eLife.28862.018)10.7554/eLife.28862.019Figure 4---figure supplement 5.Representative pH and \[Cl^-^\] maps of I^mLy^ and *Clensor* in lysosomes of J774A.1 cells in the absence and presence of 10 μM U18666A that gives a cell culture model of NP-C.(**A**) Representative images of lysosomes labeled with *Clensor* in the Alexa 647 (**R**) channel and pseudocolored R/G images are shown. Scale bar: 10 μm (**B**) Representative images of lysosomes labeled with pH sensor I^mLy^ in the Oregon Green (OG) channel (**G**), Atto647 channel (**R**) and pseudocolored G/R images are shown. Scale bar: 10 μm (**C**) pH and Cl^-^ levels in lysosomes in the presence and absence of 10 μM U18666A. Error bars indicate s.e.m. (n = 10 cells, ≥50 endosomes). To directly compare the results from ncr-1 knockdowns that yielded a worm model of Niemann Pick C in [Figure 3](#fig3){ref-type="fig"}, we also employed U18666A a selective inhibitor for NPC1 protein to induce NP-C cell model. We first confirmed that *Clensor* could traffic to the lysosome in this cell culture model ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). We found a dramatic lysosomal hypoacidification and no significant change of lysosomal \[Cl^-^\]. This matches our observation in a *C. elegans* model for NP-C.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.019](10.7554/eLife.28862.019)

Treating J774A.1 cells and THP-1 cells with a global chloride ion channel blocker, such as NPPB (5-Nitro-2-(3-phenylpropylamino) benzoic acid), lowered lysosomal chloride concentrations to 104 and 106 mM respectively, indicating that *Clensor* was capable of measuring pharmacologically induced lysosomal chloride changes, if any, in these cells. In Gaucher's cell culture models, murine and human cells showed a substantial decrease in lysosomal chloride to \~101 mM and \~92 mM respectively. This is a drop of 15--25 mM (13‒21% change) chloride, as compared to a drop of \~10 µM in lysosomal proton concentrations. In Niemann-Pick A/B cell culture models, murine and human macrophages showed an even more dramatic decrease in lysosomal chloride to \~77 mM and \~86 mM respectively. This is also a substantial decrease of 30--40 mM (25‒34% change) chloride, as compared to a drop of \~9 µM in lysosomal proton concentrations. On average in these four cell culture models, we find that the magnitude of chloride concentration decrease is at least 3 orders of magnitude greater than proton decrease, indicating that lysosome dysfunction is easily and sensitively reflected in its lumenal chloride concentrations. A Niemann Pick C cell culture model using the inhibitor U18666A recapitulated our findings in nematode models, where only lysosomal pH, but not Cl^-^, was altered ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"})

High chloride regulates lysosome function in multiple ways {#s2-8}
----------------------------------------------------------

The ClC family protein CLC-7 is expressed mainly in the late endosomes and lysosomes ([@bib27]; [@bib36]). The loss of either ClC-7 or its β-subunit Ostm1 does not affect lysosomal pH in any way, yet leads to osteopetrosis, resulting in increased bone mass, and severe degeneration of the brain and retina ([@bib44]). Along with our studies in nematodes, this reveals a role for high chloride in lysosome function that is beyond that of a mere counter-ion in the lysosome. We therefore probed whether it could indirectly affect lysosomal function by affecting lysosomal Ca^2+^ ([@bib47]; [@bib59]; [@bib65]). We also considered the possibility that lysosomal chloride could exert a direct effect, where its reduction could impede the function of lysosomal enzymes thus affecting its degradative capacity ([@bib5]; [@bib16]; [@bib48]; [@bib79]) ([Figure 5a](#fig5){ref-type="fig"}).10.7554/eLife.28862.020Figure 5.(a) Schematic of potential roles for lysosomal chloride.Cl^-^ ions can regulate lysosomal Ca^2+^ and/or affect lysosomal enzyme function. (**b**) Representative traces of Glycyl-L-phenylalanine 2-naphthylamide (GPN) (400 μM) triggered lysosomal Ca^2+^ release in J774A.1 cells ratiometrically imaged using Fura-2 (F~340~/F~380~) in the presence and absence of 50 μM NPPB. (**c**) Representative traces of ML-SA1 (20 μM) triggered lysosomal Ca^2+^ release in *J774A.1* cells ratiometrically imaged using Fura-2 (F~340~/F~380~) in the presence and absence of 50 μM NPPB. (**d**) Quantification of lysosomal Ca^2+^ release from b) and c) given by (F~t~-F~0~/F~0~) (ΔFura-2) for n = 15 cells. (**e**) Representative images of lysosomes of J774A.1 cells labelled with TMR dextran (TMR; **G**) and LysoTracker Red (LyT; **R**) in the presence or absence of 50 μM NPPB, 200 μM GPN or 1 mM NH~4~Cl. Scale bar, 5 μm (f) Quantification of LysoTracker Red release from (e) (n = 50 cells). (**g**) Quantification of activity of the enzymes arylsulfatase B (ARSB) and Cathepsin L (Cath L) in J774A.1 cells in the absence and presence of 50 μM NPPB (n = 70 cells). Error bars indicate s.e.m. P values are as follows; \*\* = p\<0.001, \*\*\* = p\<0.0001, n.s = non significant.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.020](10.7554/eLife.28862.020)10.7554/eLife.28862.021Figure 5---figure supplement 1.Representative fluorescence images of cleaved substrates of ARSB and cathepsin L (E), DAPI (D) merge of E and D channels and respective pseudocolour E/D maps of *J774A.1* cells with and without 50 µM NPPB.Scale bar: 5 μm. To demonstrate chloride ion levels directly influence lysosome function, 50 µM of chloride channel inhibitor -- NPPB was employed to decrease lysosomal chloride without affecting lysosomal pH ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Upon incubation of 50 µM of NPPB for 30 min, the activity of arylsulfatase B (ARSB) was reduced *ca.* 50% while the activity of its upstream enzyme cathepsin L which activates cathepsin C, ([@bib17]) is still unchanged. It reveals that decrease of chloride ions level directly attenuate cathepsin C activity.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.021](10.7554/eLife.28862.021)10.7554/eLife.28862.022Figure 5---figure supplement 2.(a) Lysosomal pH and (b) chloride levels measured by I^mLy^ and *Clensor* in J774A.1 cells with increasing concentrations of NPPB.Here we show that by varying doses of NPPB that at \< 100 µM of NPPB, we can selectively reduce lysosomal Cl- without changing in lysosomal pH. Consequently all further studies that use NPPB do so at 50 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.28862.022](10.7554/eLife.28862.022)

Lysosomes are also intracellular Ca^2+^ stores with free Ca^2+^ ranging between \~400--600 µM ([@bib15]; [@bib45]). The principal Ca^2+^ channel responsible for lysosomal Ca^2+^ release is Mucolipin TRP channel 1 (TRPML1). We therefore sought to estimate lysosomal Ca^2+^ by measuring Ca^2+^ that is released from the lysosome using two different triggers under conditions of normal and reduced lysosomal Cl^-^. Glycyl-L-phenylalanine 2-naphthylamide (GPN) is a substrate for Cathepsin C, which when added to cells, gets cleaved in the lysosome to release naphthylamine that is known to compromise the integrity of the lysosomal membrane, leading to a leakage of ions such as Ca^2+^ into the cytosol ([@bib8]; [@bib35]; [@bib53]). This has been used to induce lysosomal Ca^2+^ release.

The cytosol of J774A.1 cells are labeled with \~3 µM Fura2-AM to ratiometrically image cytosolic Ca^2+^ elevation upon its release, if at all, from the lysosome. After addition of 400 µM GPN, cells were continuously imaged ratiometrically over 15--20 mins. Shortly after GPN addition, a burst of Ca^2+^ was observed in the cytosol, corresponding to released lysosomal Ca^2+^ ([Figure 5b](#fig5){ref-type="fig"}). When the same procedure was performed on cells that had been incubated with 50 µM NPPB that reduces lysosomal Cl-, the amount of lysosomal Ca^2+^ released was significantly reduced ([Figure 5b--d](#fig5){ref-type="fig"}) We then performed a second, more targeted way to release lysosomal Ca^2+^ into the cytosol, by using 20 µM ML-SA1 which specifically binds to and opens the TRPML1 channel on lysosomes ([@bib65]). We found that when lysosomal Cl^-^ was reduced with NPPB, lysosomal Ca^2+^ release into the cytosol was near negligible ([Figure 5c--d)](#fig5){ref-type="fig"}. Taken together this indicates that high lysosomal Cl^-^ is necessary for effective lysosomal Ca^2+^ release, possibly by affect lysosomal Ca^2+^ accumulation.

We next investigated whether reducing lysosomal chloride directly impacted the activity of any lysosomal enzymes. *In vitro* enzymology of Cathepsin C, a lysosome-resident serine protease has revealed that increasing Cl^-^ increased its enzymatic activity ([@bib16]; [@bib49]). Further, the crystal structure of Cathepsin C shows bound chloride ions close to the active site ([@bib16]; [@bib76]). We therefore used GPN cleavage to probe Cathepsin C activity in the lysosome upon reducing Cl^-^ with NPPB. GPN cleavage by Cathepsin C releases naphthylamine which compromises lysosomal membrane integrity leading to proton leakage from the lysosome into the cytosol. This hypoacidifies the lysosomes resulting in reduced LysoTracker labeling as the labeling efficiency of the latter is directly proportional to compartment acidity.

Lysosomes are pre-labeled with TMR-Dextran, and LysoTracker intensities are normalized to the fluorescence intensity of TMR-Dextran, given as G/R. Hypoacidifying lysosomes by addition of 1 mM NH~4~Cl indeed reduced LysoTracker labeling, as expected ([Figure 5e--f](#fig5){ref-type="fig"}). A similar effect was also obtained upon GPN addition. The presence or absence of NPPB showed no change in LysoTracker labeling in cells ([Figure 5e--f)](#fig5){ref-type="fig"}, indicating that NPPB by itself caused no alteration in lysosomal pH. However, when GPN was added to NPPB treated cells LysoTracker staining was remarkably well preserved ([Figure 5e and f](#fig5){ref-type="fig"}) indicating preservation of lysosomal membrane integrity because GPN was no longer effectively cleaved by Cathepsin C when lysosomal Cl^-^ was reduced. Unlike other cathepsins, Cathepsin C does not undergo autoactivation but requires processing by Cathepsin L and Cathepsin S to convert it into active Cathepsin C ([@bib17]). We measured the activity of the upstream cathepsins such as Cathepsin L using fluorogenic substrates in the presence and absence of NPPB ([Figure 5g](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). We observed no effect of chloride levels on Cathepsin L activity. This indicates that low Cathepsin C activity is not due to decreased amounts of mature Cathepsin C in the lysosome, but rather, reduced activity of mature Cathepsin C ([Figure 5g](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Based on reports suggesting that arylsulfatase B activity was also affected by low chloride ([@bib81]), we similarly investigated a fluorogenic substrate for arylsulfatase and found that NPPB treatment impeded arylsulfatase cleavage in the lysosome. Taken together, these results suggest that high lysosomal chloride is integral to the activity of key lysosomal enzymes and that reducing lysosomal chloride affects their function.

Conclusions {#s2-9}
-----------

The lysosome is the most acidic organelle within the cell. This likely confers on it a unique ionic microenvironment, reinforced by its high lumenal chloride, that is critical to its function ([@bib82]). Using a DNA-based, fluorescent reporter called *Clensor* we have been able to create quantitative, spatial maps of chloride *in vivo* and measured lysosomal chloride. We show that, in *C. elegans*, lysosomes are highly enriched in chloride and that when lysosomal chloride is depleted, the degradative function of the lysosome is compromised. Intrigued by this finding, we explored the converse: whether lysosomes that had lost their degradative function -- as seen in lysosomal storage disorders - showed lower lumenal chloride concentrations. In a host of *C. elegans* models for various lysosomal storage disorders, we found that this was indeed the case. In fact, the magnitude of change in chloride concentrations far outstrips the change in proton concentrations by at least three orders of magnitude.

To see whether chloride dysregulation correlated with lysosome dysfunction more broadly, we studied murine and human cell culture models of Gaucher's disease, Niemann-Pick A/B disease and Niemann Pick C. We found that in mammalian cells too, lysosomes are particularly rich in chloride, surpassing even extracellular chloride levels. Importantly, chloride values in all the mammalian cell culture models revealed magnitudes of chloride dysregulation that were similar to that observed in *C. elegans*.

Our findings suggest more widespread and as yet unknown roles for the single most abundant, soluble physiological anion in regulating lysosome function. Decrease in lysosomal chloride impedes the release of calcium from the lysosome implicating an interplay between these two ions in the lysosome. It is also possible that chloride accumulation could facilitate lysosomal calcium enrichment through the coupled action of multiple ion channels. The ability to quantitate lysosomal chloride enables investigations into the broader mechanistic roles of chloride ions in regulating multiple functions performed by the lysosome. As such, given that chloride dysregulation shows a much higher dynamic range than hypoacidification, quantitative chloride imaging can provide a much more sensitive measure of lysosome dysfunction in model organisms as well as in cultured cells derived from blood samples that can be used in disease diagnoses and screening applications.

Materials and methods {#s3}
=====================

Reagents {#s3-1}
--------

All fluorescently labeled oligonucleotides were HPLC-purified and obtained from IBA-GmBh (Germany) and IDT (Coralville, IA, USA). Unlabeled oligonucleotides were purchased from IDT (Coralville, IA, USA). The peptide nucleic acids (PNA) oligomer, P was synthesized using standard solid phase Fmoc chemistry on Nova Syn TGA resin (Novabiochem, Germany) using analytical grade reagents (Applied Biosystems, USA), purified by reverse phase HPLC (Shimadzu, Japan) as previously reported and stored at −20°C until further use ([@bib57]).

Bovine serum albumin (66 kDalton), nigericin, valinomycin, monensin, chloride ionophore I,** Isopropyl β-D-1-thiogalactopyranoside** (IPTG), amitriptyline hydrochloride, 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and conduritol β epoxide (CBE) were obtained from Sigma (USA). LysoTracker Deep Red, TMR-Dextran (10 kDa) and Oregon Green 488 maleimide was obtained from Molecular Probes, Invitrogen (USA). Lysosomal enzyme kits namely lysosomal sulfatase assay kit was purchased from Marker Gene (USA); Magic Red Cathepsin L assay kit from Immunochemistry Technologies. Gly-Phe β-naphthylamide was purchased from Santa Cruz Biotechnology (USA). All other reagents were purchased from Sigma-Aldrich (USA) unless otherwise specified. BSA was maleylated according to a previously published protocol ([@bib29]). Trizol was purchased from Invitrogen (U.S.A.).

Sample preparation {#s3-2}
------------------

All oligonucleotides were ethanol precipitated and quantified by their UV absorbance. For I-switch (I4^cLY^~A488/A647~) sample preparation, 5 μM of I4 and I4′ were mixed in equimolar ratios in 20 mM potassium phosphate buffer, pH 5.5 containing 100 mM KCl. The resulting solution was heated to 90°C for 5 min, cooled to the room temperature at 5°C/15 mins and equilibrated at 4°C overnight. Samples were diluted and used within 7 days of annealing. A sample of *Clensor* was similarly prepared using HPLC purified oligonucleotides and PNA oligomer at a final concentration of 10 μM by mixing D1, D2 and P (see Table S1 for sequence information) in equimolar ratios in 10 mM sodium phosphate buffer, pH 7.2 and annealed as described above. For I^mLy^, Oregon Green maleimide was first conjugated to the thiol labeled oligonucleotide ([@bib33]). Briefly, to 10 µM thiol labelled oligonucleotide in HEPES pH 7.4, 500 µM of TCEP (tris-carboxyethylphosphine) was added to reduce the disulfide bonds. After 1 hr at room temperature, 50 µM Oregon Green Maleimide was added and the reaction was kept overnight at room temperature. The reaction mixture was purified using an Amicon cutoff membrane filter (3 kDa, Millipore) to remove unreacted dye ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). A sample of I^mLy^ was similarly prepared using HPLC purified oligonucleotides at a final concentration of 5 μM by mixing I^mLY^ ~OG~ and I^mLY^~AT647~ (see Table S1 for sequence information) in equimolar ratios in 10 mM sodium phosphate buffer, pH 7.2 and annealed as described above. Prior to use, all buffer stock solutions were filtered using 0.22 μm disk filters (Millipore, Germany).

*C. elegans* methods and strains {#s3-3}
--------------------------------

Standard methods were followed for the maintenance of *C. elegans*. Wild type strain used was the *C. elegans* isolate from Bristol, strain N2 ([@bib11]). Strains used in the study, provided by the Caenorhabditis Genetics Center (CGC), are RRID:[WB-STRAIN:RB920](https://scicrunch.org/resolver/WB-STRAIN:RB920) *clh-6(ok791),* RRID:[WB-STRAIN:FF451](https://scicrunch.org/resolver/WB-STRAIN:FF451) *unc-32(f131),* RRID:[WB-STRAIN:CB189](https://scicrunch.org/resolver/WB-STRAIN:CB189) *unc-32(e189),* RRID:[WB-STRAIN:MT7531](https://scicrunch.org/resolver/WB-STRAIN:MT7531) *ppk-3(n2835),* RRID:[WB-STRAIN:VC3135](https://scicrunch.org/resolver/WB-STRAIN:VC3135) *gba-3(gk3287),* RRID:[WB-STRAIN:VC183](https://scicrunch.org/resolver/WB-STRAIN:VC183) *ppt-1(gk139), and* RRID:[WB-STRAIN:XT7](https://scicrunch.org/resolver/WB-STRAIN:XT7) *cln-3.2(gk41) I; cln-3.3(gk118) cln-3.1(pk479)*. Transgenics used in this study, also provided by the CGC, are RRID:[WB-STRAIN:GS1912](https://scicrunch.org/resolver/WB-STRAIN:GS1912) *arIs37 \[*p*myo-3::ssGFP\]*, a transgenic strain that expresses ssGFP in the body wall muscles, which is secreted in the pseudocoelom and endocytosed by coelomocytes and RRID:[WB-STRAIN:RT258](https://scicrunch.org/resolver/WB-STRAIN:RT258) *pwIs50 \[lmp-1::GFP + Cb-unc-119(+)\]*, a transgenic strain expressing GFP-tagged lysosomal marker LMP-1. Genes, for which mutants were unavailable, were knocked down using Ahringer library based RNAi methods ([@bib38]). The RNAi clones used were: *L4440* empty vector control, *ncr-1* (clone F02E8.6, Ahringer Library), *ostm1* (clone F42A8.3, Ahringer Library), *snx-3* (clone W06D4.5, Ahringer Library), *manba* (clone C33G3.4, Ahringer Library), *aman-1* (clone F55D10.1, Ahringer Library), *sul-3* (clone C54D2.4, Ahringer Library), gba*-3* (clone F11E6.1, Ahringer Library) and *asm1* (clone B0252.2, Ahringer Library).

Coelomocyte labeling experiments {#s3-4}
--------------------------------

Coelomocyte labeling and competition experiments were carried out with I4^cLY^~A647,~ and *Clensor~A647~* as described previously by our lab ([@bib71]). For microinjections, the samples were diluted to 100 nM using 1X Medium 1 (150 mM NaCl, 5 mM KCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 20 mM HEPES, pH 7.2). Injections were performed, in the dorsal side in the pseudocoelom, just opposite to the vulva, of one-day old wild type hermaphrodites using an Olympus IX53 Simple Inverted Microscope (Olympus Corporation of the Americas, Center Valley, PA) equipped with 40X, 0.6 NA objective, and microinjection setup (Narishige, Japan). Injected worms were mounted on 2.0% agarose pad and anesthetized using 40 mM sodium azide in M9 buffer. In all cases labeling was checked after 1 hr incubation at 22°C.

Colocalization experiments {#s3-5}
--------------------------

I4^cLY^~A647~ or *Clensor~A647~* sample was diluted to 100 nM using 1X Medium 1 and injected in 10 *arIs37 \[*p*myo-3::ssGFP\]* hermaphrodites as described previously by our lab ([@bib71]). Imaging and quantification of the number of coelomocytes labeled, after 1 hr of incubation, was carried out on the Leica TCS SP5 II STED laser scanning confocal microscope (Leica Microsystems, Inc., Buffalo Grove, IL) using an Argon ion laser for 488 nm excitation and He-Ne laser for 633 excitation with a set of dichroics, excitation, and emission filters suitable for each fluorophore. Cross talk and bleed-through were measured and found to be negligible between the GFP/Alexa 488/BAC channel and Alexa 647 channel.

RNAi experiments {#s3-6}
----------------

Bacteria from the Ahringer RNAi library expressing dsRNA against the relevant gene was fed to worms, and measurements were carried out in one-day old adults of the F1 progeny ([@bib38]). RNA knockdown was confirmed by probing mRNA levels of the candidate gene, assayed by RT-PCR. Briefly, total RNA was isolated using the Trizol-chloroform method; 2.5 μg of total RNA was converted to cDNA using oligo-dT primers. 5 μL of the RT reaction was used to set up a PCR using gene-specific primers. Actin mRNA was used as a control. PCR products were separated on a 1.5% agarose-TAE gel. Genes in this study that were knocked down by RNAi correspond to clh-6, ncr-1 and ostm-1 that showed expected 1.1 kb (clh-6); 1.1 kb (ncr-1); 0.9 kb (ostm-1) etc ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

*In vitro* fluorescence measurements {#s3-7}
------------------------------------

Fluorescence spectra were measured on a FluoroMax-4 Scanning Spectrofluorometer (Horiba Scientific, Edison, NJ, USA) using previously established protocols ([@bib51]; [@bib60]). Briefly, I4^cLY^~A488/A647~ was diluted to 50 nM in 1X pH clamping buffer of desired pH for all *in vitro* fluorescence experiments. All samples were vortexed and equilibrated for 30 min at room temperature. The samples were excited at 488 nm and emission collected between 505--750 nm. A calibration curve was obtained by plotting the ratio of donor emission intensity (D) at 520 nm and acceptor intensity (A) at 669 nm (for A488/A647) as a function of pH. Mean of D/A from three independent experiments and their s.e.m were plotted for each pH value. For *in vitro* calibration of I^mLy^, 50 nM of the sensor is diluted into 1X pH clamping buffer of desired pH. Oregon Green and Atto 647N are excited at 490 nm and 645 nm respectively. Emission spectra for Oregon Green and Atto 647N were collected between 500--550 nm and 650--700 nm respectively. A calibration curve was obtained by plotting the ratio of Oregon Green (G) at 520 nm and Atto 647N (R) at 665 nm (for G/R) as a function of pH. Mean of G/R from three independent experiments and their s.e.m were plotted for each pH value.

For chloride measurements, 10 μM stock of *Clensor* was diluted to a final concentration of 200 nM using 10 mM sodium phosphate buffer, pH 7.2 and incubated for 30 min at room temperature prior to experiments. BAC and Alexa 647 were excited at 435 nm for BAC and 650 nm for Alexa 647 respectively. Emission spectra of BAC and Alexa 647 were collected between 495--550 nm and 650--700 nm respectively. In order to study the chloride sensitivity of *Clensor*, final chloride concentrations ranging between 5 mM to 80 mM were achieved by addition of microliter aliquots of 1 M stock of NaCl to 400 μL of sample. Emission intensity of BAC at 505 nm (G) was normalized to emission intensity of Alexa 647 at 670 nm (R). Fold change in R/G ratio was calculated from the ratio of R/G values at two specific values of \[Clˉ\], either 5 mM and 80 mM or 5 mM and 120 mM as mentioned in the text.

*In vivo* measurements of pH and chloride pH {#s3-8}
--------------------------------------------

Clamping and real time measurement experiments were carried out with I4^cLY^~A488/A647~ as described by our lab previously ([@bib51]; [@bib71]). For microinjections, the I-switch sample was diluted to 500 nM using 1X Medium 1. Briefly, worms were incubated at 22˚C for 1 hr post microinjection and then immersed in clamping buffers (120 mM KCl, 5 mM NaCl, 1 mM MgCl~2~, 1 mM CaCl~2~, 20 mM HEPES) of varying pH, containing 100 µM nigericin and 100 µM monensin. In order to facilitate entry of the buffer into the body, the cuticle was perforated at three regions of the body using a microinjection needle. After 75 mins incubation in the clamping buffer, coelomocytes were imaged using wide field microscopy. Three independent measurements, each with 10 worms, were made for each pH value.

Chloride clamping and real time measurements were carried out using *Clensor.* Worms were injected with 2 μM of *Clensor* and incubated at 22˚C for 2 hr. To obtain the chloride calibration profile, the worms were then immersed in the appropriate chloride clamping buffer containing a specific concentration of chloride, 100 μM nigericin, 100 μM valinomycin, 100 μM monensin and 10 μM chloride ionophore I for 45 mins at room temperature. Chloride calibration buffers containing different chloride concentrations were prepared by mixing the 1X chloride positive buffer (120 mM KCl, 20 mM NaCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 20 mM HEPES, pH, 7.2) and 1X chloride negative buffer (120 mM KNO~3~, 20 mM NaNO~3~, 1 mM Ca(NO~3~)~2~, 1 mM Mg(NO~3~)~2~, 20 mM HEPES, pH 7.2) in different ratios.

For real-time lysosomal pH or chloride measurements, 10 hermaphrodites were injected with I4^cLY^~A488/A647~ or *Clensor* respectively and incubated at 22°C for 1 hr. Worms were then anaesthetized and imaged on a wide field inverted microscope for pH measurements and confocal microscope for chloride measurements.

Cell culture methods and maintenance {#s3-9}
------------------------------------

Mouse alveolar macrophage J774A.1 cells were a kind gift from Prof Deborah Nelson, Department of Pharmacological and Physiological Sciences, the University of Chicago, cultured in Dulbecco's Modified Eagle's Medium/F-12 (1:1) (DMEM-F12) (Invitrogen Corporation,USA) containing 10% heat inactivated Fetal Bovine Serum (FBS) (Invitrogen Corporation, USA). THP-1 monocyte cell line was obtained from late Professor Janet Rowley's Lab at the University of Chicago. Cells were cultured in RPMI 1640 containing 10% heat-inactivated FBS, 10 mM HEPES, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin, and maintained at 37°C under 5% CO2. All reagents and medium were purchased from (Invitrogen Corporation,USA). THP-1 monocytic cells were differentiated into macrophages in 60 mm dishes containing 3 ml of the RPMI 1640 medium containing 10 nM PMA over 48 hr. These cells are not on the list of commonly misidentified cell lines maintained by the International Cell Line Authentication Committee. The sources of each cell line used in this study are as mentioned above and were used directly by us without additional authentication beyond that provided by the sources. All cells were regularly checked for mycoplasma contamination and were found to be negative for contamination as assayed by DAPI staining.

*In cellulo* measurements pH and chloride {#s3-10}
-----------------------------------------

Chloride clamping and measurements were carried out using *Clensor* using a previously published protocol from our lab ([@bib60]). J774A.1 and THP-1 cells were pulsed and chased with 2 μM of *Clensor*. Cells are then fixed with 200 μL 2.5% PFA for 2 min at room temperature, washed three times and retained in 1X PBS. To obtain the intracellular chloride calibration profile, perfusate and endosomal chloride concentrations were equalized by incubating the previously fixed cells in the appropriate chloride clamping buffer containing a specific concentration of chloride, 10 μM nigericin, 10 μM valinomycin, and 10 μM tributyltin chloride (TBT-Cl) for 1 hr at room temperature.

Chloride calibration buffers containing different chloride concentrations were prepared by mixing the 1X chloride positive buffer (120 mM KCl, 20 mM NaCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 20 mM HEPES, pH, 7.2) and 1X - chloride negative buffer (120 mM KNO~3~, 20 mM NaNO~3~, 1 mM Ca(NO~3~)~2~, 1 mM Mg(NO~3~)~2~, 20 mM HEPES, pH 7.2) in different ratios.

For real-time chloride measurements, cells are pulsed with 2 μM of *Clensor* followed by a 60 min chase. Cells are then washed with 1X PBS and imaged. To see whether *Clensor* can detect changes in Clˉ accumulation under perturbed conditions, we treated cells with 50 µM NPPB, which is a well-known non-specific Clˉ channel blocker. Cells were labeled with 2 μM *Clensor* for 30 mins and chased for 30 mins at 37°C. The cells were then chased for 30 mins in media containing 50 µM NPPB and then imaged.

To estimate the chloride accumulation in the lysosomes of Gaucher's Disease in two cell models that is murine J774A.1 and human THP-1 cells, glucosylceramide storage was induced catalytically inactivating the enzyme acid β-glucosidase, using its well-known inhibitor conduritol β epoxide (CBE) ([@bib26]; [@bib63]). These are both well-documented murine and human cell culture models of Gaucher\'s disease. Macrophage cells were cultured with 400 µM CBE for 48 hr. Cells were then pulsed and chased with 2 μM *Clensor* as previously described.

To estimate chloride accumulation in the lysosomes of Niemann Pick A/B disease, the same murine and human cell lines were used, and the activity of acid sphingomyelinase (ASM) in these macrophage cell lines was inhibited using the well-known inhibitor, amitriptyline hydrochloride ([@bib7]; [@bib42]). Cells were labeled with 2 μM *Clensor* for 30 mins and chased for 30 mins at 37°C. The cells were then chased for 30 mins in media containing 10 µM amitriptyline hydrochloride and then imaged.

*In cellulo* pH clamping and measurement experiments were carried out with I^mLy^ with modifications to protocols described by our lab previously ([@bib52], [@bib51]). J774A.1 and THP-1 cells were pulsed and chased with 500 nM of I^mLy^. Cells are then fixed with 200 μL 2.5% PFA for 20 mins at room temperature, washed three times and retained in 1X PBS. To obtain the intracellular pH calibration profile, perfusate and endosomal pH were equalized by incubating the previously fixed cells in the appropriate pH clamping buffer clamping buffers (120 mM KNO~3~, 5 mM NaNO~3~, 1 mM Mg(NO~3~)~2~, 1 mM Ca(NO~3~)~2~, 20 mM HEPES, MES and NaOAc) of varying pH, containing 25 µM nigericin and 25 µM monensin for 30 mins at room temperature.

For real-time pH measurements, cells are pulsed with 500 nM of I^mLy^ followed by a 60 mins chase. Cells are then washed with 1X PBS and imaged. pH measurements in the lysosomes of Gaucher's Disease and of Niemann Pick A/B disease, in the two cell models that is murine J774A.1 and human THP-1 cells, were carried out similar to the protocol above using 500 nM of I^mLy^.

Microscopy {#s3-11}
----------

Wide field microscopy was carried out on IX83 research inverted microscope (Olympus Corporation of the Americas, Center Valley, PA, USA) using a 60X, 1.42 NA, phase contrast oil immersion objective (PLAPON, Olympus Corporation of the Americas, Center Valley, PA, USA) and Evolve Delta 512 EMCCD camera (Photometrics, USA). Filter wheel, shutter and CCD camera were controlled using Metamorph Premier Ver 7.8.12.0 (Molecular Devices, LLC, USA), suitable for the fluorophores used. Images on the same day were acquired under the same acquisition settings. All the images were background subtracted taking mean intensity over an adjacent cell free area. Mean intensity in each endosome was measured in donor (D) and acceptor (A) channels. Alexa 488 channel images (D) were obtained using 480/20 band pass excitation filter, 520/40 band pass emission filter and a 89016- ET - FITC/Cy3/Cy5 dichroic filter. Alexa 647 channel images (A) were obtained using 640/30 band pass excitation filter, 705/72 band pass emission filter and 89016- ET - FITC/Cy3/Cy5 dichroic filter. For FRET channel images were obtained using the 480/20 band pass excitation filter, 705/72 band pass emission filter and 89016- ET - FITC/Cy3/Cy5 dichroic filter. Mean intensity in each endosome was measured in donor and acceptor channels. A ratio of donor to acceptor intensities (D/A) was obtained from these readings. Pseudocolor images were generated by calculating the D/A ratio per pixel. Confocal images were captured with a Leica TCS SP5 II STED laser scanning confocal microscope (Leica Microsystems, Inc., Buffalo Grove, IL, USA) equipped with 63X, 1.4 NA, oil immersion objective. Alexa 488 was excited using an Argon ion laser for 488 nm excitation, Alexa 647 using He-Ne laser for 633 excitation and BAC using Argon ion laser for 458 nm excitation with a set of dichroics, excitation, and emission filters suitable for each fluorophore.

Ratiometric calcium imaging of Fura-2 was carried out on an Olympus IX81 microscope equipped with a 40x objective, NA = 1.2. Excitation of Fura-2 is performed using 340/26 and 380/10 nm excitation filters, equipped with a 455 nm dichroic mirror and a 535/40 nm emission filter. Exposure time was kept at 100 ms for all the imaging experiments to minimize phototoxicity.

Image analysis {#s3-12}
--------------

Images were analyzed with ImageJ ver 1.49 (NIH, USA). For pH measurements Alexa 488 and Alexa 647 images were overlapped using ImageJ and endosomes showing colocalization were selected for further analysis. Intensity in each endosome was measured in donor (D) and FRET (A) channels and recorded in an OriginPro Sr2 b9.2.272 (OriginLab Corporation, Northampton, MA, USA) file from which D/A ratio of each endosome was obtained. The mean D/A of each distribution were converted to pH according to the intracellular calibration curve. Data was represented as mean pH value ± standard error of the mean. Data for pH clamping experiments was analysed similarly.

For chloride measurements, regions of cells containing lysosomes in each Alexa 647 (R) image were identified and marked in the ROI plugin in ImageJ. The same regions were identified in the BAC (G) image recalling the ROIs and appropriate correction factor for chromatic aberration if necessary. After background subtraction, intensity for each endosome was measured and recorded in an Origin file. A ratio of R to G intensities (R/G) was obtained from these values by dividing the intensity of a given endosome in the R image with the corresponding intensity in the G image. For a given experiment, mean \[Clˉ\] of an organelle population was determined by converting the mean R/G value of the distribution to \[Clˉ\] values according to the intracellular calibration profile. Data was presented as mean of this mean \[Clˉ\] value ± standard error of the mean. Data for chloride clamping experiments was analyzed similarly.

Colocalization of GFP and Alexa 647 was determined by counting the numbers of Alexa 647 positive puncta that colocalize with GFP and representing it as a Pearson\'s correlation coefficient.

Lysosomal labelling in coelomocytes {#s3-13}
-----------------------------------

Temporal mapping of I-switch and *Clensor* was done in 10 worms of *pwIs50 \[lmp-1::GFP + Cb-unc-119(+)\]* as previously described by our lab ([@bib71]). Briefly, worms were injected with 500 nM of I4^cLY^~A647~ or *Clensor~A647~*, incubated at 22°C for 1 hr, and then imaged using Leica TCS SP5 II STED laser scanning confocal microscope (Leica Microsystems, Inc., Buffalo Grove, IL, USA). Colocalization of GFP and I4^cLY^~A647~ or *Clensor~A647~* was determined by counting the numbers of Alexa647 positive puncta that colocalize with GFP positive puncta and expressing them as a percentage of the total number of Alexa 647 positive puncta. In order to confirm lysosomal labeling in a given genetic background, the same procedure was performed on the relevant mutant or RNAi knockdown in *pwIs50 \[lmp-1::GFP + Cb-unc-119(+)\].*

Statistics and general methods {#s3-14}
------------------------------

All pH and chloride clamping experiments ([Figure 1b](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) were performed in triplicates and the standard error of mean (s.e. m) values are plotted with the number of cells considered being mentioned in each legend. Experiment with murine macrophage, J774A.1 and THP-1 cells ([Figure 4](#fig4){ref-type="fig"}) has been performed in triplicates. Ratio of standard error of the mean is calculated for n = 20 cells and n = 10 cells and is plotted in [Figure 4d and e](#fig4){ref-type="fig"} respectively. All pH and chloride measurements in *C.elegans* of indicated genetic backgrounds ([Figures 2c](#fig2){ref-type="fig"} and [3c](#fig3){ref-type="fig"} and [Figure 2---figure supplement 1c](#fig2s1){ref-type="fig"} ) were carried out in n = 10 worms and the standard error of mean (s.e.m) values are plotted with the number of cells considered being mentioned in each legend.

DNA stability assay {#s3-15}
-------------------

Coelomocyte labeling for stability assay were carried out with I4^cLY^~A647,~ and *Clensor~A647~.* For microinjections, the samples were diluted to 500 nM using 1X Medium 1 (150 mM NaCl, 5 mM KCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 20 mM HEPES, pH 7.2). Post injection the worms are incubated at 22°C. After requisite time the injected worms are anesthetized in 40 mM sodium azide in M9 buffer and mounted on a glass slide containing 2% agarose pad. Worms were imaged using Olympus IX83 research inverted microscope (Olympus Corporation of the Americas, Center Valley, PA, USA). The average whole cell intensity in the Alexa 647 channel was plotted as a function of time ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"})

J774A.1 and THP-1 macrophage cells labeling was carried out using 500 nM *Clensor~A647~* using 1X Medium 1 (150 mM NaCl, 5 mM KCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 20 mM HEPES, pH 7.2). Cells were pulsed for 30 mins and then chased at 37°C for the indicated time points. The average whole cell intensity in the Alexa 647 channel was plotted as a function of time ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}).

Fura-2AM imaging {#s3-16}
----------------

Cells were loaded with 3 μM Fura-2 AM in HBSS (137 mM NaCl, 5 mM KCl, 1.4 mM CaCl~2~, 1 mM MgCl~2~, 0.25 mM Na~2~HPO~4, ~0.44 mM KH~2~PO~4,~4.2 mM NaHCO~3~ and 10 mM glucose) at 37°C for 60 min. Post incubation cells were washed with 1X PBS and then imaged in Low Ca^2+^ or Zero Ca^2+^ buffer (145 mM NaCl, 5 mM KCl, 3 mM MgCl~2~, 10 mM glucose, 1 mM EGTA, and 20 mM HEPES (pH 7.4)). Ca^2+^ concentration in the nominally free Ca^2+^ solution is estimated to be 1--10 μM. With 1 mM EGTA, the free Ca^2+^ concentration is estimated to be \<10 nM based on the Maxchelator software (<http://maxchelator.stanford.edu/>). Florescence was recorded using two different wavelengths (340 and 380 nm) and the ratio (F~340~/F~380~) was used to calculate changes in intracellular \[Ca^2+^\].

Enzyme activity assays {#s3-17}
----------------------

Enzyme activity assays were performed in J774A.1 cells. For Cathepsin C enzyme activity; we used Gly-Phe β-naphthylamide as a substrate. Lysosomes of J774A.1 cells were pre-labeled with TMR-dextran (0.5 mg/mL; G) for 1 hr and chased in complete medium for 16 hr at 37°C. The cells were then labeled with 50 nM LysoTracker in complete medium for 30 mins at 37°C. 50 μM NPPB or 200 μM GPN were then added to the cells and incubated for 30 mins at 37°C. The cells then washed and imaged in HBSS buffer containing either NPPB or GPN. The whole cell intensity ratio (G/R) was plotted to quantify the level of LysoTracker labelling of the endosomes. For Cathepsin L and Aryl Sulfatase enzyme activity Magic Red Cathepsin L assay kit (Immunochemistry Technologies) and Lysosomal sulfatase assay kit (Marker Gene) were used. The experiment was performed using the manufacture's protocol. Briefly, cells were incubated with 1X Magic Red Cathepsin L assay probe or 200 μM Lysosomal sulfatase assay probe for 4 hr in complete medium. The cells were then labelled with 10 μM Hoechst stain for 10 mins at 37°C after which the cells were washed and imaged. For low chloride containing dishes; cells were preincubated with 50 μM NPPB before the addition of the enzyme probes. The ratio of enzyme substrate whole cell intensity to that of DAPI was used to quantify enzyme activity.
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###### Sequences used for *Clensor* and I4^cLY^~A488/A647~ assemblies.

Oligo P, Oligo D1 and Oligo D2 combine to form *Clensor*. Oligo I4^cLY^~A488~ and I4^cLY^~A647~ combine to form I4^cLY^~A488/A647~. The sequences in matching colors are complementary.
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###### Lysosomal storage disorders investigated in this study, their corresponding human genes and the *C.elegans* homologues.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration and the paper was accepted for publication. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"High lumenal chloride in the lysosome is critical for lysosome function\" for consideration by *eLife*. Your article has been favorably evaluated by a Senior Editor and three reviewers, one of whom, Suzanne R Pfeffer (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individuals involved in review of your submission have agreed to reveal their identity: Haoxing Xu (Reviewer \#2) and Carsten Schultz (Reviewer \#3).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that this manuscript will not be considered further for publication in *eLife*. As you will see in the following comments, the reviewers noted a number of strengths in the use of your novel chloride sensor. However, they felt that additional work would be required to bring the work to the level of significance and novelty expected for presentation in *eLife*.

*Reviewer \#1:*

Quoting a review from Jentsch (2013), exact measurements of lysosomal \[Cl−\] have not been reported due to the lack of suitable Cl− sensors for the high \[Cl−\] at low pH. However, from measurements with cells treated with low Cl− and from model calculations, lysosomal \[Cl−\]lumen is greater than 80 mM. 2010 data strongly point to a crucial role of Cl− transport in organellar physiology that \"goes beyond merely providing the electrical shunt for proton pumping by the V-ATPase.\" Despite maintaining lysosomal conductance and normal lysosomal pH, Clcn7unc/unc mice showed lysosomal storage disease like mice lacking ClC-7. Although various proteins are known to be regulated by Cl−, the mechanism by which (mainly luminal) Cl− affects membrane traffic and organellar function has remained elusive; the 2010 analysis of Clcn5unc and Clcn7unc mice has suggested that luminal anion concentration is important all along the endosomal-lysosomal pathway.

Here, the authors use a novel, DNA based chloride sensor to try more accurately to determine lysosomal chloride levels. Like the previous work from the Jentsch lab, the findings using *C. elegans* lysosomes indicate a high level of lysosomal chloride. Chloride ion levels are decreased under conditions of lysosomal dysregulation due to mutations in genes that lead to lysosomal storage disorders. Not clear are the mechanisms underlying these observations.

Recently, the lysosome has been shown to represent a significant calcium store, and in worms, CUP-5 is the MCOLN-1 homolog that is important for lysosomal calcium levels and functions. If chloride is not the counterion for protons, it may be important for calcium homeostasis. Given that it is not clear how chloride influences lysosome function in disease states or in normal cells, it would be very important for these authors to clarify the connection between chloride accumulation defects and calcium uptake and regulation. Without this, the findings seem somewhat anecdotal, despite highlighting the recently uncovered importance of chloride ions in lysosome function. No doubt this is an interesting area for further investigation.

*Reviewer \#2:*

Cl^-^ transport across endosomal and lysosomal membranes are known to be crucial for lysosomal acidification and physiology, but the underlying mechanisms are poorly understood, largely due to the lack of the methods that can be used to reliably monitor luminal Cl^-^ levels in live cells. The authors previously reported the development of a DNA-based fluorescent reporter (i.e., *Clensor*) for Cl^-^. Compared with protein-based ion-sensing probes, a major advantage for DNA-based probes is their relative insensitivity to pH, which is low in the endosomes and lysosomes. Building on this exciting development in the field, the authors now report the use of *Clensor* in *C. elegans* and mammalian phagocytes, providing evidence that a decrease in lysosomal \[Cl^-^\] is likely to be a primary pathogenic factor in a number of lysosome storage diseases (LSDs). Overall, the cell biology and imaging experiments in the study were carefully designed, and the results were mostly clean and convincing, and carefully interpreted. Both the use of *Clensor* and the major conclusions of the paper are of substantial interests to researchers working on lysosome biology, anion channels and transporters, membrane transport, organellar channels and transporters, and LSDs. The manuscript can be improved if following points are taken into consideration.

1\) Cl^-^ channels are known to exhibit poor anion selectivity. What is the anion selectivity for *Clensor*? When lysosomal \[Cl^-^\] is reduced in some LSD cells, assuming that lysosome lumen is still electroneutral and iso-osmotic, what are substituted anions? Phosphate is probably an obvious candidate. Therefore, it would be helpful if the authors can show the effects of NO3(-) and PO4(3-) in *Clensor in vitro*.

2\) Lysosomal delivery of *Clensor* might be slowed down in LSD cells, compared with wild-type (WT) cells. Could trafficking defects contribute to the observed reduction in lysosomal \[Cl^-^\]? Given the 40 mM difference in late endosomal vs. lysosomal \[Cl^-^\], it is plausible that a block in endosome maturation might affect the \[Cl^-^\] measurement. I would assume that the calibration curves and maximal signals are identical for WT and LSD cells. Is that the case?

*Reviewer \#3:*

The work of Krishnan and co-workers describes the use of previously published fluorescent sensors for measuring lysosomal pH and Cl levels. Elegantly, the work was performed in circulating nematode macrophages as well as cultured mammalian cells. This is a very exciting application and the authors observe that a lack of chloride levels correlates with a loss of degrading capacity of the lysosome. The authors follow the hypothesis that the drop-in chloride content is responsible for driving lysosomal function. They tested model conditions for lysosomal storage diseases in *C. elegans* and found indeed reduced chloride levels under such conditions. However, this is not a prove that the chloride ion levels are instrumental. The question remains if chloride levels are the key component in lysosomal dysfunction or a by-stander effect.

The authors argue that CF patients show lysosomal distress symptoms at the molecular level (changes in enzyme activities) similar to Niemann-Pick patients. What the authors do not consider in their argumentation is that CF patients share very little of the NPC phenotype. There is no early neurodegeneration in CF nor a liver accumulation of lipids such as cholesterol or sphingosine. As a result, the conclusions driven by the present study do not hold. Down to the bare bones, the study reveals very interesting data regarding the chloride ion levels in lysosomes but lacks any mechanistic insight. Unfortunately, there is no consideration (or even mentioning) of the calcium levels in the lysosome that have received quite some attention in the regulation of lysosomal function and signaling lately (for instance, see Medina et al. Nature Cell Biology 17, 288-299 (2015)). Chloride might change driving forces for lysosomal im- or export but a direct switching function through changes in protein conformation as is known for calcium ions would be a large surprise.

For publication in *eLife*, I would expect a more profound mechanistic insight of what chloride ions are doing in lysosomes. So far, the authors present highly interesting observations in very relevant cells followed by a conclusion section that is in my opinion not coherent with the observed phenotype (in CF). To make this work suitable for *eLife*, I would expect measuring and/or manipulating calcium levels under conditions where lysosomal chloride levels are high or low, respectively. In addition, the authors could manipulate chloride levels in lysosomes acutely and observe effects spontaneously.

In summary, I suggest to reject this manuscript until the above-mentioned experiment sets have been performed and a mechanistic model is presented.

10.7554/eLife.28862.026

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*Reviewer \#1:*

*Quoting a review from Jentsch (2013), exact measurements of lysosomal \[Cl−\] have not been reported due to the lack of suitable Cl− sensors for the high \[Cl−\] at low pH. However, from measurements with cells treated with low Cl− and from model calculations, lysosomal \[Cl−\]lumen is greater than 80 mM. 2010 data strongly point to a crucial role of Cl− transport in organellar physiology that \"goes beyond merely providing the electrical shunt for proton pumping by the V-ATPase.\" Despite maintaining lysosomal conductance and normal lysosomal pH, Clcn7unc/unc mice showed lysosomal storage disease like mice lacking ClC-7. Although various proteins are known to be regulated by Cl−, the mechanism by which (mainly luminal) Cl− affects membrane traffic and organellar function has remained elusive; the 2010 analysis of Clcn5unc and Clcn7unc mice has suggested that luminal anion concentration is important all along the endosomal-lysosomal pathway.*

*Here, the authors use a novel, DNA based chloride sensor to try more accurately to determine lysosomal chloride levels. Like the previous work from the Jentsch lab, the findings using C. elegans lysosomes indicate a high level of lysosomal chloride. Chloride ion levels are decreased under conditions of lysosomal dysregulation due to mutations in genes that lead to lysosomal storage disorders. Not clear are the mechanisms underlying these observations.*

*Recently, the lysosome has been shown to represent a significant calcium store, and in worms, CUP-5 is the MCOLN-1 homolog that is important for lysosomal calcium levels and functions. If chloride is not the counterion for protons, it may be important for calcium homeostasis. Given that it is not clear how chloride influences lysosome function in disease states or in normal cells, it would be very important for these authors to clarify the connection between chloride accumulation defects and calcium uptake and regulation. Without this, the findings seem somewhat anecdotal, despite highlighting the recently uncovered importance of chloride ions in lysosome function. No doubt this is an interesting area for further investigation.*

We now include additional experiments that address how low chloride in the lysosome could mechanistically connect to lysosomal storage disease. We pursued two hypotheses. One, suggested by this reviewer, was that low chloride could impede lysosomal Ca^2+^ accumulation, which is known to compromise lysosome function (1--3). We also explored whether chloride could directly impact the proper function of specific lysosomal enzymes (1).

Our studies revealed both mechanisms to be operational. Briefly, selectively inhibiting chloride channels with NPPB resulted in reducing lysosomal Ca^2+^ ([Figure 5B-D](#fig5){ref-type="fig"}). Further, the lysosomal enzymes cathepsin C and aryl sulfatase B showed reduced enzymatic activity upon reducing lysosomal Cl^-^ with NPPB ([Figure 5E-G](#fig5){ref-type="fig"}).

The results of these experiments are now presented as [Figure 5](#fig5){ref-type="fig"} of the revised manuscript, along with the associated discussion in the subsection "High chloride regulates lysosome function in multiple ways".

*Reviewer \#2:*

*\[...\] 1) Cl^-^ channels are known to exhibit poor anion selectivity. What is the anion selectivity for Clensor? When lysosomal \[Cl^-^\] is reduced in some LSD cells, assuming that lysosome lumen is still electroneutral and iso-osmotic, what are substituted anions? Phosphate is probably an obvious candidate. Therefore, it would be helpful if the authors can show the effects of NO3(-) and PO4(3-) in Clensor in vitro*.

We thank the reviewer for this suggestion. [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} shows the selectivity of *Clensor* to various anions in the form of their sodium salts. This reveals that the sensitivity of *Clensor* to diverse biologically abundant anions including NO~3~^-^ and PO~4~^3-^ is negligible. This is attributed to the fact that *Clensor\'s* chloride-sensing module, BAC, undergoes collisional quenching selectively with halide ions because of their well-matched HOMO-LUMO energies (2,3). However, chloride is the most abundant physiological anion ([@bib4]) hence BAC acts as a chloride sensor in biological systems.

*2) Lysosomal delivery of Clensor might be slowed down in LSD cells, compared with wild-type (WT) cells. Could trafficking defects contribute to the observed reduction in lysosomal \[Cl^-^\]? Given the 40 mM difference in late endosomal vs. lysosomal \[Cl^-^\], it is plausible that a block in endosome maturation might affect the \[Cl^-^\] measurement. I would assume that the calibration curves and maximal signals are identical for WT and LSD cells. Is that the case?*

The reviewer\'s point is well taken. Before any Cl^-^ measurements were made in any mutant *C. elegans,* we performed colocalization studies of *Clensor* with LMP-1::GFP transgenic worms, where the relevant lysosomal storage disorder gene was knocked down by RNAi. These revealed \~80% colocalization at t = 60 min post injecting *Clensor* in all mutant backgrounds studied here, indicating that trafficking of the probe was not affected. Further, in the context of clh-6 worms, though there is an imbalance in chloride concentrations, lumenal pH of these compartments matches that of wildtype lysosomes suggesting that these compartments are indeed likely to be lysosomes. Several other mutants e.g., ncr-1, aman and manba showed *Clensor* accumulated in grossly misshapen and/or enlarged LMP1::GFP positive compartments, further reinforcing that the compartments are indeed lysosomes swollen due to the accumulated material.

In murine and human macrophages, we pre-labelled lysosomes with TMR-Dextran (0.5 mg/mL) using literature protocols (5), treat cells with U18666A and Conduritol β-epoxide (CBE) to induce Niemann Pick C and Gaucher\'s cellular phenotype, only then pulse *Clensor* for 30 min, chased for 60 min, and scored for co-localization with TMR-Dextran. Amitriptyline (AH) and NPPB were added 30 min after pulsing and chasing of *Clensor* to lysosomes. We observed that *Clensor* colocalized with lysosomes under each of these conditions, indicating that they do not suffer trafficking defects in these cell culture models of lysosomal storage diseases. This data is now presented as [Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}.

*Reviewer \#3:*

*The work of Krishnan and co-workers describes the use of previously published fluorescent sensors for measuring lysosomal pH and Cl levels. Elegantly, the work was performed in circulating nematode macrophages as well as cultured mammalian cells. This is a very exciting application and the authors observe that a lack of chloride levels correlates with a loss of degrading capacity of the lysosome. The authors follow the hypothesis that the drop-in chloride content is responsible for driving lysosomal function. They tested model conditions for lysosomal storage diseases in C. elegans and found indeed reduced chloride levels under such conditions. However, this is not a prove that the chloride ion levels are instrumental. The question remains if chloride levels are the key component in lysosomal dysfunction or a by-stander effect.*

Please see response to reviewer \#1, point \#1. In a nutshell, this is not a by-stander effect.

*The authors argue that CF patients show lysosomal distress symptoms at the molecular level (changes in enzyme activities) similar to Niemann-Pick patients. What the authors do not consider in their argumentation is that CF patients share very little of the NPC phenotype. There is no early neurodegeneration in CF nor a liver accumulation of lipids such as cholesterol or sphingosine. As a result, the conclusions driven by the present study do not hold.*

Actually, we never implied any connection between Niemann Pick C with CF. We only cited published literature that correlated reduced arylsulfatase activity and acid sphingomyelinase activity in cells derived from patients with CF (12,13). These enzymes are defective in mucopolysaccharidoses VI and Niemann Pick A/B diseases(14). These are distinct diseases from Niemann Pick C disease.

However, given the extensive new data that we added, we have dropped mention of CF as it can prove distracting to the reader.

*Down to the bare bones, the study reveals very interesting data regarding the chloride ion levels in lysosomes but lacks any mechanistic insight. Unfortunately, there is no consideration (or even mentioning) of the calcium levels in the lysosome that have received quite some attention in the regulation of lysosomal function and signaling lately (for instance, see Medina et al. Nature Cell Biology 17, 288-299 (2015)). Chloride might change driving forces for lysosomal im- or export but a direct switching function through changes in protein conformation as is known for calcium ions would be a large surprise.*

Please see response to reviewer \#1, point \#1. Briefly, lysosomal Ca^2+^ is indeed depleted when lysosomal chloride is reduced. However, the functions of specific lysosomal enzymes such as cathepsin C and aryl sulfatase B, is also affected. There is *in vitro* evidence that high Cl^-^ is necessary for the activity of these enzymes (15--19). Data to this effect is now presented as [Figure 5](#fig5){ref-type="fig"} in the revised main manuscript.

*For publication in eLife, I would expect a more profound mechanistic insight of what chloride ions are doing in lysosomes. So far, the authors present highly interesting observations in very relevant cells followed by a conclusion section that is in my opinion not coherent with the observed phenotype (in CF). To make this work suitable for eLife, I would expect measuring and/or manipulating calcium levels under conditions where lysosomal chloride levels are high or low, respectively. In addition, the authors could manipulate chloride levels in lysosomes acutely and observe effects spontaneously.*

We have addressed this comment. Please see response to reviewer \#1, point \#1.
